PALVELLA THERAPEUTICS, INC.
PVLA · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Goin Kathleen: Form 4
Insider disclosure · Filed · Report period 21 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001583648 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PVLA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 353 W. Lancaster Avenue, Suite 200, Wayne, PA, 19087
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- PIERIS PHARMACEUTICALS, INC. (to 12 Dec 2024), Marika Inc. (to 18 Dec 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields